Form 8-K Perspective Therapeutics For: Oct 23

Go back to Form 8-K Perspective Therapeutics For: Oct 23

BTIG on Perspective Therapeutics Inc (CATX): 'would be buyers on weakness'

October 26, 2026 5:13 AM EDT

BTIG analyst Jeet Mukherjee reiterated a Buy rating and $14.00 price target on Perspective Therapeutics Inc (NYSE: CATX).

The analyst comments "CATX presented its largest and longest follow-up VMT-- NET dataset to date at ESMO, with the full cohort 2 now in and the first look at cohort... More